Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Colby who wrote (3404)	12/11/1997 12:27:00 PM
From: Musa Goksel Bulat	Respond to of 23519

I agree with you they should have announced this before UK approval. I believe many of the big guys knew about it and took this opportunity to crash the stock. I didn't take any position till UK approval, I bought some on the day of announcement. I doubled my position yesturday and also bougt some june 20 calls. As long as Viagra is not effectice for pshycal problems, yesturdays' action is irrational. I strongly beleive that Viagra will eventually help Muse sales.

To: Colby who wrote (3404)	12/11/1997 2:38:00 PM
From: LoLoLoLita	Read Replies (2) \| Respond to of 23519

Colby, the mgmt. DID WARN about just exactly this kind of problem in ramping up production. It's all in the last 10-Q. ---------- The Company has limited experience in manufacturing and selling MUSE (alprostadil) in commercial quantities. Since the commercial launch of MUSE (alprostadil) in January 1997, the Company has experienced product shortages due to higher than expected demand and difficulties encountered in scaling up production of MUSE (alprostadil). The Company has initiated the build out of 90,000 square feet of additional manufacturing space, and it is currently seeking a location for construction of a European manufacturing operation. If the Company encounters further difficulties with its current manufacturing facility or delays in completion or regulatory approval of its new manufacturing facility, capacity constraints could continue for an extended period of time, which would have a material adverse effect on the Company's business, financial condition and results of operations. ---------- Hopefully, we won't have any stupid cry-baby lawsuits against VVUS by people who didn't do their DD, and didn't read the SEC filings. Cheers, David